Mussel-inspired dopamine-CuII coatings for sustained in situ generation of nitric oxide for prevention of stent thrombosis and restenosis
Source abstract
Abstract
Nitric oxide (NO) is a highly potent, yet short-lived bioactive molecule with a broad spectrum of physiological functions. Continuous and controllable in situ generation of NO from vascular stent surface can effectively prevent restenosis and thrombosis after its implantation. In this study, inspired by the adhesion and protein cross-linking in the mussel byssus, through immersing the stents into an aqueous solution with dopamine (DA) and copper ions (CuII), we developed a one-step metal-catecholamine assembled strategy to prepare a durable in situ NO-generating biomimetic coating (DA-CuII). Due to the high NO catalytic efficacy and robust chelation of CuII into the DA-CuII network, the coated stents exhibited excellent hemocompatibility. The coating also catalytically decomposed endogenous S-nitrosothiols (RSNOs) from fresh blood, and locally generated NO for over 30 days with a flux comparable to its physiological range (0.5-4 × 10-10 mol × cm-2 × min-1). Moreover, the optimized biomimetic coatings displayed specific cell selectivity to significantly enhance endothelial cell (EC) growth while substantially inhibit smooth muscle cell (SMC) growth and migration. This feature impressively promoted regeneration of a new endothelial cell layer after stent implantation, hence improved the anti-thrombogenic and anti-restenosis qualities of vascular stents in vivo. We envision that our long-term in situ NO-generating coatings could serve as biosurfaces for long-term prevention of stent thrombosis and restenosis.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Nitric Oxide and Endothelin Effects · Aortic Disease and Treatment Approaches · Polymer Surface Interaction Studies
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (47)
Show source-provided references
1. Global, regional, and national burden of cardiovascular diseases for 10 causes, 1990 to 201510.1016/j.jacc.2017.04.052 ↗
2. Long-term safety of drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis10.1016/j.jacc.2015.04.017 ↗
3. Stable titania nanostructures on stainless steel coronary stent surface for enhanced corrosion resistance and endothelialization10.1002/adhm.201601353 ↗
4. The formation of an anti-restenotic/anti-thrombotic surface by immobilization of nitric oxide synthase on a metallic carrier10.1016/j.actbio.2013.12.043 ↗
5. Biomimetic cardiovascular stents for in vivo re-endothelialization10.1016/j.biomaterials.2016.06.042 ↗
6. Surface modification of implanted cardiovascular metal stents: from antithrombosis and antirestenosis to endothelialization10.1002/jbm.a.34714 ↗
7. Surface engineering of cardiovascular stent with endothelial cell selectivity for in vivo re-endothelialisation10.1016/j.biomaterials.2012.12.036 ↗
8. Nanomatrix coated stent enhances endothelialization but reduces platelet, smooth muscle cell, and monocyte adhesion under physiologic conditions10.1021/acsbiomaterials.7b00676 ↗
9. Vascular endothelial growth factor-bound stents: application of in situ capture technology of circulating endothelial progenitor cells in porcine coronary model10.1111/joic.12087 ↗
10. Functional Layer-by-layer thin films of inducible nitric oxide (NO) synthase oxygenase and polyethylenimine: modulation of enzyme loading and NO-release activity10.1021/acsami.7b17575 ↗
11. Nitric oxide releasing coronary stent: a new approach using layer-by-layer coating and liposomal encapsulation10.1002/smll.201600337 ↗
12. Enzyme-functionalized vascular grafts catalyze in-situ release of nitric oxide from exogenous NO prodrug10.1016/j.jconrel.2015.05.283 ↗
13. Evolution of covered stents in the contemporary era: clinical application, materials and manufacturing strategies using nanotechnology10.1016/j.biotechadv.2012.12.010 ↗
14. Nitric oxide release: Part II. Therapeutic applications10.1039/c2cs15273h ↗
15. Nitric oxide: a guardian for vascular grafts?10.1021/cr200008n ↗
16. Polymer-based nitric oxide therapies: recent insights for biomedical applications10.1002/adfm.201101707 ↗
17. State of the art, challenges and perspectives in the design of nitric oxide-releasing polymeric nanomaterials for biomedical applications10.1016/j.biotechadv.2015.01.005 ↗
18. Nitric oxide donors for cardiovascular implant applications10.1002/smll.201200458 ↗
19. Catalytic formation of nitric oxide mediated by Ti-Cu coatings provides multifunctional interfaces for cardiovascular applications10.1002/admi.201701487 ↗
20. Nitric oxide release: Part I. Macromolecular scaffolds10.1039/c2cs15272j ↗
21. Enzyme prodrug therapy achieves site-specific, personalized physiological responses to the locally produced nitric oxide10.1021/acsami.8b01658 ↗
22. Immobilization of selenocystamine on TiO2 surfaces for in situ catalytic generation of nitric oxide and potential application in intravascular stents10.1016/j.biomaterials.2010.10.039 ↗
23. Nitric oxide producing coating mimicking endothelium function for multifunctional vascular stents10.1016/j.biomaterials.2015.06.016 ↗
24. Mussel-inspired catalytic selenocystamine-dopamine coatings for long-term generation of therapeutic gas on cardiovascular stents10.1016/j.biomaterials.2018.06.008 ↗
25. Transition-metal-mediated release of nitric oxide (NO) from S-nitroso-N-acetyl-d-penicillamine (SNAP): potential applications for endogenous release of NO at the surface of stents via corrosion products10.1021/acsami.6b00145 ↗
26. Evaluation of promoting effect of a novel Cu-bearing metal stent on endothelialization process from in vitro and in vivo studies10.1038/s41598-017-17737-9 ↗
27. Insights into the aggregation/deposition and structure of a polydopamine film10.1021/la5026608 ↗
28. Nitric oxide release: part III. Measurement and reporting10.1039/c2cs15271a ↗
29. Direct thrombin inhibitor-bivalirudin functionalized plasma polymerized allylamine coating for improved biocompatibility of vascular devices10.1016/j.biomaterials.2012.07.050 ↗
30. Synergetic coordination and catecholamine chemistry for catalytic generation of nitric oxide on vascular stents10.1038/s41427-018-0052-3 ↗
31. Reduced platelet adhesion and improved corrosion resistance of superhydrophobic TiO2-nanotube-coated 316L stainless steel10.1016/j.colsurfb.2014.11.028 ↗
32. Mussel-inspired coating of polydopamine directs endothelial and smooth muscle cell fate for re-endothelialization of vascular devices10.1002/adhm.201200073 ↗
33. Origin of long-term storage stability and nitric oxide release behavior of CarboSil polymer doped with S-nitroso-N-acetyl-D-penicillamine10.1021/acsami.5b07501 ↗
34. Copper-incorporated collagen/catechol film for in situ generation of nitric oxide10.1021/acsbiomaterials.5b00131 ↗
35. The effects of Cu-doped TiO2 thin films on hyperplasia, inflammation and bacteria infection10.3390/app5041016 ↗
36. Sustained nitric oxide release from a tertiary s-nitrosothiol-based polyphosphazene coating10.1021/acsami.6b12888 ↗
37. Electropolymerization of dopamine for surface modification of complex-shaped cardiovascular stents10.1016/j.biomaterials.2014.05.047 ↗
38. The prevention of restenosis in vivo with a VEGF gene and paclitaxel co-eluting stent10.1016/j.biomaterials.2012.11.006 ↗
39. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly10.1152/ajpcell.1996.271.5.C1424 ↗
40. Surface-mediated functional gene delivery: an effective strategy for enhancing competitiveness of endothelial cells over smooth muscle cells10.1016/j.biomaterials.2013.01.065 ↗
41. Gallic acid tailoring surface functionalities of plasma-polymerized allylamine-coated 316L SS to selectively direct vascular endothelial and smooth muscle cell fate for enhanced endothelialization10.1021/am405124z ↗
42. A self-assembled polydopamine film on the surface of magnetic nanoparticles for specific capture of protein10.1039/c2nr30316g ↗
43. Role of a copper (I)-dependent enzyme in the anti-platelet action of S-nitrosoglutathione10.1111/j.1476-5381.1996.tb15704.x ↗
44. Platelet cell-surface protein disulphide-isomerase mediated S-nitrosoglutathione consumption10.1042/BJ20040759 ↗
45. Catalytic generation of nitric oxide from S-nitrosothiols using immobilized organoselenium species10.1016/j.biomaterials.2006.08.019 ↗
46. In vitro investigation of enhanced hemocompatibility and endothelial cell proliferation associated with quinone-rich polydopamine coating10.1021/am3027635 ↗
47. Effects of polydopamine functionalized titanium dioxide nanotubes on endothelial cell and smooth muscle cell10.1016/j.colsurfb.2014.01.030 ↗